Skip to main content

Table 2 Demographic characteristics of the participants

From: Direct venous inoculation of Plasmodium falciparum sporozoites for controlled human malaria infection: a dose-finding trial in two centres

Variable

Total

ID 2500

IV 50

IV 200

IV 800

IV 3200

DVI 3200

N

36

6

3

3

9

9

6

Age in years*

26 (19; 43)

24 (21; 42)

24 (23; 27)

27 (27; 32)

26 (21; 43)

27 (24; 30)

29 (19; 40)

Gender, Female:Male#

11:25

1:5

0:3

0:3

4:5

2:7

4:2

Height in cm*

176 (159; 196)

178 (166; 196)

186 (178; 190)

169 (167; 186)

177 (166; 189)

176 (163; 196)

167 (159; 172)

Weight in kg*

73 (55; 111)

83 (63; 92)

77 (70; 100)

77 (68; 82)

74 (59; 90)

71 (64; 111)

61.1 (55; 73)

BMI in kg/m2*

23.9 (18.5; 29.4)

24.1 (22.9; 29.4)

22.1 (21.3; 28.9)

24.3 (22.3; 28.7)

23.8 (19.1; 26.6)

24.1 (18.5; 28.8)

22.8 (19.1; 24.8)

Hb in g/dl*

14.7 (11.8; 16.7)

15.1 (12.5; 15.3)

15.6 (15.1; 16.2)

16.1 (14.7; 16.7)

14.2 (12.0; 16.6)

14.6 (11.8; 15.7)

13.3 (12.3; 15.1)

Platelets/nL*

248 (138; 396)

231 (172; 260)

237 (138; 340)

263 (210; 307)

221 (176; 261)

246 (193; 396)

321 (259; 364)

  1. *Median (min; max), #N, ID: intradermal, IV: intravenous (dose-escalation group), DVI: direct venous inoculation (verification group).